Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...

Despite regulation changes in the Chinese healthcare industry, we think CSPC is well-positioned to maintain relatively strong revenue growth. First, generic drugs normally face the most severe price ...

AI is reshaping labs and Clever Culture’s tech is gaining Big Pharma attention as diagnostics and cleanrooms go digital. ...

Mettler-Toledo’s capital efficiency, strong moat, and robust free cash flow make it a standout investment. Click here to find ...

Global Nutricosmetics Market was valued at USD 7.13 Billion in 2024. Total revenue is expected to grow at a CAGR of 7.9% from 2025 to 2032 ...

Dow Inc. DOW and DuPont de Nemours, Inc. DD are prominent U.S.-based chemical manufacturers, producing a wide range of ...

On May 29, Indian equity markets rebounded, snapping a two-session losing streak, with the Nifty 50 closing in the green on the monthly expiry day. Despite some intraday volatility, a sharp recovery ...

A health reporter explains why suggesting that medical research be limited, controlled, or replaced by ‘in-house’ ...

Her wealth surpasses that of well-known entrepreneurs like Kiran Mazumdar-Shaw of Biocon and Falguni Nayar of Nykaa. In 2023, ...

West Pharmaceutical Services shares have dropped 35% in 2025, despite better-than-expected Q1 results, with forward guidance ...